Skip to content
Pharm PhD
  • Blog
  • About
  • Blog
  • About
Read more about the article My PhD Journey in the U.S. | Week 82 | 03/08/2026 – 03/14/2026
Daily Life

My PhD Journey in the U.S. | Week 82 | 03/08/2026 – 03/14/2026

Pivot Week

0 Comments
April 11, 2026
Read more about the article [Paper Review #13] Predicting the protein interaction landscape of a free-living bacterium with pooled-AlphaFold3
Knowledge

[Paper Review #13] Predicting the protein interaction landscape of a free-living bacterium with pooled-AlphaFold3

https://link.springer.com/article/10.1038/s44320-026-00189-7 Predicting the protein interaction landscape of a free-living bacterium with pooled-AlphaFold3   Key figures Figure 2: Establishes the two core technical claims of the paper, namely the size bias…

0 Comments
March 25, 2026
Read more about the article My PhD Journey in the U.S. | Week 81 | 03/01/2026 – 03/07/2026
Daily Life

My PhD Journey in the U.S. | Week 81 | 03/01/2026 – 03/07/2026

Go for it

0 Comments
March 21, 2026
Read more about the article [Paper Review #12] A rational blueprint for the design of chemically-controlled protein switches
Knowledge

[Paper Review #12] A rational blueprint for the design of chemically-controlled protein switches

https://www.nature.com/articles/s41467-021-25735-9 A rational blueprint for the design of chemically-controlled protein switches Key figures [Figure 4]: It is the central conceptual advance because it shows how OFF-switch CDHs were converted into…

0 Comments
March 18, 2026
Read more about the article [Paper Review #11] Explainable Physicochemical Determinants of Protein–Ligand Binding via Non-Covalent Interactions
Knowledge

[Paper Review #11] Explainable Physicochemical Determinants of Protein–Ligand Binding via Non-Covalent Interactions

https://www.biorxiv.org/content/10.64898/2026.03.03.707476v1 Explainable Physicochemical Determinants of Protein–Ligand Binding via Non-Covalent Interactions Key figures [Figure 1]: Establishes the main contribution by pairing InteractBind dataset construction with ExplainBind’s attention-supervised sequence model, making the…

0 Comments
March 16, 2026
Read more about the article [Paper Review #10] A conformation-specific ON-switch for controlling CAR T cells with an orally available drug
Knowledge

[Paper Review #10] A conformation-specific ON-switch for controlling CAR T cells with an orally available drug

https://www.pnas.org/doi/10.1073/pnas.1911154117 A conformation-specific ON-switch for controlling CAR T cells with an orally available drug Key figures [Figure 2E]: Quantifies drug-dependent dynamic range (nanomolar ON vs micromolar OFF) and cross-validates switching…

0 Comments
March 16, 2026
Read more about the article My PhD Journey in the U.S. | Week 80 | 02/22/2026 – 02/28/2026
Daily Life

My PhD Journey in the U.S. | Week 80 | 02/22/2026 – 02/28/2026

Perfect Weather

0 Comments
March 8, 2026
Read more about the article [Paper Review #9] Chemogenetic Control of Nanobodies
Knowledge

[Paper Review #9] Chemogenetic Control of Nanobodies

https://www.nature.com/articles/s41592-020-0746-7 Chemogenetic Control of Nanobodies Key figures [Fig. 1]: Defines the LAMA design principle (cpDHFR insertion into nanobody CDRs) and demonstrates ligand-triggered loss of target binding with reversible kinetics and…

0 Comments
March 1, 2026
Read more about the article My PhD Journey in the U.S. | Week 79 | 02/15/2026 – 02/21/2026
Daily Life

My PhD Journey in the U.S. | Week 79 | 02/15/2026 – 02/21/2026

KRAS Kickers💪

0 Comments
March 1, 2026
Read more about the article [Paper Review #8] Direct control of CAR T cells through small molecule-regulated antibodies
Knowledge

[Paper Review #8] Direct control of CAR T cells through small molecule-regulated antibodies

https://www.nature.com/articles/s41467-020-20671-6 Direct control of CAR T cells through small molecule-regulated antibodies Key figures [Figure 3]: Establishes that a single-module “conditional CAR” retains potent target killing yet is reversibly and dose-dependently…

0 Comments
February 28, 2026
  • Go to the previous page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 12
  • Go to the next page

Recent Posts

  • [Paper Review #25] Mutant p53 protein accumulation is selectively targetable by proximity-inducing drugs
    [Paper Review #25] Mutant p53 protein accumulation is selectively targetable by proximity-inducing drugs
    June 9, 2026/
    0 Comments
  • [Paper Review #24] Discovery of Covalent Ligands with AlphaFold3
    [Paper Review #24] Discovery of Covalent Ligands with AlphaFold3
    June 9, 2026/
    0 Comments
  • My PhD Journey in the U.S. | Week 90 | 05/03/2026 – 05/09/2026
    My PhD Journey in the U.S. | Week 90 | 05/03/2026 – 05/09/2026
    June 1, 2026/
    0 Comments
  • [Paper Review #23] De novo mapping of α-helix recognition sites on protein surfaces using unbiased libraries
    [Paper Review #23] De novo mapping of α-helix recognition sites on protein surfaces using unbiased libraries
    May 31, 2026/
    0 Comments
  • [Paper Review #22] Recognition and reprogramming of E3 ubiquitin ligase surfaces by α-helical peptides
    [Paper Review #22] Recognition and reprogramming of E3 ubiquitin ligase surfaces by α-helical peptides
    May 29, 2026/
    0 Comments
  • [Paper Review #21] Cyclic peptide structure prediction and design using AlphaFold2
    [Paper Review #21] Cyclic peptide structure prediction and design using AlphaFold2
    May 28, 2026/
    0 Comments

On Social Media

  • Opens in a new tab
  • Opens in a new tab

Share This

ⓒ 2026 PharmPhD.com. All rights reserved.